AcquisitionOther
Axsome Therapeutics, Inc. acquired Sunosi
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Axsome Therapeutics, Inc. -> Sunosi · $300 million
Upon closing, the transaction will accelerate Axsome’s transition to a global commercial entity, leverage Axsome’s first-in-class Digital Centric Commercialization platform ahead of potential near-term launches of AXS-05 in depression and AXS-07 in migraine,
Open source record (SEC) ↗